Literature DB >> 25644348

Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis.

Hye Won Park1, Na Mi Lee2, Ji Hee Kim3, Kyo Sun Kim1, Soo-Nyung Kim4.   

Abstract

BACKGROUND: Growing evidence indicates that fish oil-containing lipid emulsions have a beneficial effect on parenteral nutrition-associated cholestasis (PNAC) in adults; however, data are limited in neonates regarding the effect of fish oil on PNAC.
OBJECTIVE: We conducted a meta-analysis of studies that addressed the effect of fish oil-containing lipid emulsions on reversing and preventing PNAC.
METHODS: We searched PubMed, the EMBASE database, and the Cochrane Library for this systematic review and meta-analysis. The methodologic assessment of studies was performed with the Jadad scale and the Newcastle-Ottawa Scale. Comprehensive Met-Analysis version 2.0 was used for the statistical analysis. We performed a meta-analysis with the primary outcomes of reversal of PNAC and the occurrence of PNAC in newborn infants, including preterm infants, after parenteral administration of fish oil-containing lipid emulsions.
RESULTS: Of the 36 studies identified, 7 fulfilled the inclusion criteria and were used in this meta-analysis, including 3 studies with 93 participants in which reversal of PNAC was an outcome and 4 studies with 1012 participants on preventing PNAC. The use of fish oil-containing lipid emulsions was more likely to reverse PNAC (OR: 6.14; 95% CI: 2.27, 16.6; P < 0.01), but the use of fish oil-containing lipid emulsions did not have a significant effect on the development of PNAC (OR: 0.56; 95% CI: 0.28, 1.10; P = 0.09) compared with soybean-based or olive oil-based lipid emulsions.
CONCLUSIONS: The pooled data suggest that the use of fish oil-containing lipid emulsions is effective for reversing PNAC but cannot prevent PNAC in neonates who require prolonged parenteral nutritional support.
© 2015 American Society for Nutrition.

Entities:  

Keywords:  Neonate; Omegaven; SMOFlipid; fish oil; parenteral nutrition–associated cholestasis

Mesh:

Substances:

Year:  2014        PMID: 25644348     DOI: 10.3945/jn.114.204974

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  27 in total

Review 1.  Working group reports: evaluation of the evidence to support practice guidelines for nutritional care of preterm infants-the Pre-B Project.

Authors:  Daniel J Raiten; Alison L Steiber; Susan E Carlson; Ian Griffin; Diane Anderson; William W Hay; Sandra Robins; Josef Neu; Michael K Georgieff; Sharon Groh-Wargo; Tanis R Fenton
Journal:  Am J Clin Nutr       Date:  2016-01-20       Impact factor: 7.045

Review 2.  Fish Oil Based Lipid Emulsions for the Treatment of Intestinal Failure Associated Liver Disease: Nothing Fishy About it!

Authors:  Rishi Bolia; Anshu Srivastava
Journal:  Indian J Pediatr       Date:  2019-04-10       Impact factor: 1.967

Review 3.  Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure.

Authors:  Mikko P Pakarinen
Journal:  Pediatr Surg Int       Date:  2015-03-29       Impact factor: 1.827

Review 4.  Visceral transplantation in patients with intestinal-failure associated liver disease: Evolving indications, graft selection, and outcomes.

Authors:  Jason S Hawksworth; Chirag S Desai; Khalid M Khan; Stuart S Kaufman; Nada Yazigi; Raffaele Girlanda; Alexander Kroemer; Thomas M Fishbein; Cal S Matsumoto
Journal:  Am J Transplant       Date:  2018-04-06       Impact factor: 8.086

Review 5.  Intravenous Lipid Emulsions in Parenteral Nutrition.

Authors:  Gillian L Fell; Prathima Nandivada; Kathleen M Gura; Mark Puder
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

6.  Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2015-06-27       Impact factor: 4.406

Review 7.  Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.

Authors:  Gregory Guthrie; Muralidhar Premkumar; Douglas G Burrin
Journal:  Nutr Clin Pract       Date:  2017-01-27       Impact factor: 3.080

Review 8.  Pathophysiology, prevention, treatment, and outcomes of intestinal failure-associated liver disease.

Authors:  Noora H Al-Shahwani; David L Sigalet
Journal:  Pediatr Surg Int       Date:  2016-12-27       Impact factor: 1.827

Review 9.  Parenteral lipid emulsions in the preterm infant: current issues and controversies.

Authors:  Lauren C Frazer; Camilia R Martin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2021-01-29       Impact factor: 5.747

10.  Lipid emulsions for parenterally fed preterm infants.

Authors:  Vishal Kapoor; Manoj N Malviya; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2019-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.